Allspring Global Investments Holdings, LLC
Position in PBYI — Puma Biotechnology, Inc.
CIK 1890906
CHARLOTTE, NC
Position in PBYI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$145,533
+$36,482 QoQ
Shares Held
17,945
+5.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 160 holders
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $810,668,643 across 76 Biotechnology names. PBYI ranks #73 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
170,829 | $158,490,019 | |
| 2 | EXEL |
Exelixis, Inc.
|
1,998,471 | $108,736,806 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
140,631 | $69,855,635 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
742,547 | $55,304,900 | |
| 5 | ASND |
Ascendis Pharma A/S
|
178,738 | $47,672,997 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
523,192 | $45,491,543 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,700 | $43,460,737 | |
| 8 | TWST |
Twist Bioscience Corp
|
418,129 | $43,017,110 |
All Filings in PBYI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,533 | 17,945 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $109,051 | 17,066 | Shares | Defined | 2026-05-05 | |
| 2024-09-30 | $1,700 | 667 | Shares | Defined | 2024-10-18 | |
| 2022-03-31 | $545,224 | 189,314 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $751,488 | 247,200 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||